Share This Post

Wie können wir helfen?

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

You are here:
You do not have access to this post.

Share This Post

Zur Werkzeugleiste springen